ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. (NASDAQ: ICAD) announced today it will showcase its ProFound Breast Health Suite of AI solutions, including the newly released ProFound Cloud, powered by Google Cloud and Google Health AI architecture, while also highlighting its recently announced partnership with Densitas, a global leader in AI solutions for breast cancer screening, at the Society for Breast Imaging (SBI) annual symposium, April 11-14 in Montreal, Canada.
ICAD and Densitas Partner to Enhance Precision Breast Health With Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluationExpands access to iCAD's
ICAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
iCAD, Inc. (NASDAQ: ICAD) announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels.
ICAD Partners With RAD-AID To Advance Breast Cancer Detection Using AI In Underserved Regions
ICAD Partners With RAD-AID To Advance Breast Cancer Detection Using AI In Underserved Regions
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
NASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial availability of ProFound Cloud. The
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
Newly released capabilities -- limiting the number of marks on a 3D view, color-coding lesion marks, and color-coding the ProFound Scorecard -- enhance radiologists' interpretability and efficiencyNAS
Earnings Call Summary | ICAD Inc(ICAD.US) Q4 2023 Earnings Conference
The following is a summary of the ICAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript:Financial Performance:iCAD reported annual revenue of $17.3 million in 2023, a decrease of 13% compared to 2022, du
Icad: Q4 Earnings Insights
icad (NASDAQ:ICAD) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:01 PM.Here's what investors need to know about the announcement.Earningsicad beat estimated earnings by 60.0%, repo
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, Vs. Street Est of $4.3M
04:03 PM EDT, 03/12/2024 (MT Newswires) -- Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M
ICAD Non-GAAP EPS of -$0.02 Beats by $0.03, Revenue of $4.74M Beats by $0.46M
ICAD 4Q EPS 5c >ICAD
ICAD 4Q EPS 5c >ICAD
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. • MINISO Group Holding (NYSE:MNSO) is likely to report quarterly earnings at $0.27
ICAD Q4 2023 Earnings Preview
There's Reason For Concern Over ICAD, Inc.'s (NASDAQ:ICAD) Massive 39% Price Jump
iCAD, Inc. (NASDAQ:ICAD) shares have had a really impressive month, gaining 39% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since the share price is still down a
ICad to Present Three Mammography Studies at Radiology Conference; Shares Rise
iCad (ICAD) said Wednesday that it will present three studies related to mammography at the European Congress of Radiology annual meeting in Vienna. The company said that one of the studies showed tha
ICAD's AI Shows Promise in Breast Cancer Detection
iCAD, Inc. (NASDAQ: NASDAQ:ICAD), a company specializing in AI-powered cancer detection solutions, presented new clinical data at the European Congress of Radiology (ECR) annual meeting in Vienna, which took place from February 28 to March 3, 2024.
ICAD Stock Jumps 11% Ahead of Medical Meeting Presentations
ICAD Adds Renowned Radiologist Dr. Hricak to Board
iCAD, Inc. (NASDAQ: NASDAQ:ICAD), a provider of AI-powered solutions for early cancer detection, announced the appointment of Dr. Hedvig Hricak to its Board of Directors.
Press Release: ICAD Expands Board of Directors With the Appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.c )
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.c ) Dr. Hricak offers extensive experience in radiology, real-world application of AI-enabled imaging solutio
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
No Data